Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 May 19;127(20):2391-405.
doi: 10.1182/blood-2016-03-643544. Epub 2016 Apr 11.

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

Daniel A Arber  1 , Attilio Orazi  2 , Robert Hasserjian  3 , Jürgen Thiele  4 , Michael J Borowitz  5 , Michelle M Le Beau  6 , Clara D Bloomfield  7 , Mario Cazzola  8 , James W Vardiman  9
Affiliations
Free article
Review

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

Daniel A Arber et al. Blood. .
Free article

Abstract

The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues was last updated in 2008. Since then, there have been numerous advances in the identification of unique biomarkers associated with some myeloid neoplasms and acute leukemias, largely derived from gene expression analysis and next-generation sequencing that can significantly improve the diagnostic criteria as well as the prognostic relevance of entities currently included in the WHO classification and that also suggest new entities that should be added. Therefore, there is a clear need for a revision to the current classification. The revisions to the categories of myeloid neoplasms and acute leukemia will be published in a monograph in 2016 and reflect a consensus of opinion of hematopathologists, hematologists, oncologists, and geneticists. The 2016 edition represents a revision of the prior classification rather than an entirely new classification and attempts to incorporate new clinical, prognostic, morphologic, immunophenotypic, and genetic data that have emerged since the last edition. The major changes in the classification and their rationale are presented here.

PubMed Disclaimer

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

Publication types

MeSH terms

Substances